Literature DB >> 26310867

Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus.

Tiago Rafael Veloso1, Frank Oechslin1, Yok-Ai Que2, Philippe Moreillon1, José Manuel Entenza3, Stefano Mancini1.   

Abstract

Enterococcus faecalis and Streptococcus gallolyticus cause infective endocarditis (IE), which can originate from the continuous release or translocation of low bacterial numbers into the bloodstream. In this context, IE cannot be prevented with antibiotics. We previously demonstrated that aspirin plus ticlopidine protected rats from IE due to S. gordonii and Staphylococcus aureus. Here we showed that aspirin plus ticlopidine significantly reduced vegetation weight and protected 73 and 64% rats (P < 0.005) from IE due to E. faecalis and S. gallolyticus, respectively. These results further support the potential use of aspirin plus ticlopidine for a global prevention of IE in high-risk patients. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Enterococcus faecalis; Streptococcus gallolyticus; antiplatelets; experimental endocarditis; prophylaxis

Mesh:

Substances:

Year:  2015        PMID: 26310867      PMCID: PMC4626580          DOI: 10.1093/femspd/ftv060

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  19 in total

Review 1.  Bacterial translocation from the gastrointestinal tract.

Authors:  R D Berg
Journal:  Trends Microbiol       Date:  1995-04       Impact factor: 17.079

2.  Recombination-deficient mutant of Streptococcus faecalis.

Authors:  Y Yagi; D B Clewell
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

Review 3.  Antiplatelet therapies for the treatment of cardiovascular disease.

Authors:  Alan D Michelson
Journal:  Nat Rev Drug Discov       Date:  2010-02       Impact factor: 84.694

Review 4.  Quantitative aspects of septicemia.

Authors:  P Yagupsky; F S Nolte
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

5.  Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis.

Authors:  Nandan S Anavekar; Imad M Tleyjeh; Nagesh S Anavekar; Zaur Mirzoyev; James M Steckelberg; Christopher Haddad; Masud H Khandaker; Walter R Wilson; Krishnaswamy Chandrasekaran; Larry M Baddour
Journal:  Clin Infect Dis       Date:  2007-03-14       Impact factor: 9.079

Review 6.  The interaction of bacterial pathogens with platelets.

Authors:  J Ross Fitzgerald; Timothy J Foster; Dermot Cox
Journal:  Nat Rev Microbiol       Date:  2006-06       Impact factor: 60.633

7.  Adherence characteristics of endocarditis-derived Streptococcus gallolyticus ssp. gallolyticus (Streptococcus bovis biotype I) isolates to host extracellular matrix proteins.

Authors:  Jouko Sillanpää; Sreedhar R Nallapareddy; Kavindra V Singh; Mary J Ferraro; Barbara E Murray
Journal:  FEMS Microbiol Lett       Date:  2008-12       Impact factor: 2.742

8.  Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid.

Authors:  Damon P Eisen; G Ralph Corey; Emma S McBryde; Vance G Fowler; Jose M Miro; Chris H Cabell; Alan C Street; Marcelo Goulart Paiva; Adina Ionac; Ru-San Tan; Christophe Tribouilloy; Orathai Pachirat; Sandra Braun Jones; Natalia Chipigina; Christoph Naber; Angelo Pan; Veronica Ravasio; Rainer Gattringer; Vivian H Chu; Arnold S Bayer
Journal:  J Infect       Date:  2009-03-20       Impact factor: 6.072

9.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Authors:  Walter Wilson; Kathryn A Taubert; Michael Gewitz; Peter B Lockhart; Larry M Baddour; Matthew Levison; Ann Bolger; Christopher H Cabell; Masato Takahashi; Robert S Baltimore; Jane W Newburger; Brian L Strom; Lloyd Y Tani; Michael Gerber; Robert O Bonow; Thomas Pallasch; Stanford T Shulman; Anne H Rowley; Jane C Burns; Patricia Ferrieri; Timothy Gardner; David Goff; David T Durack
Journal:  Circulation       Date:  2007-04-19       Impact factor: 29.690

10.  A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis.

Authors:  Kwan-Leung Chan; Jean G Dumesnil; Bibiana Cujec; Anthony J Sanfilippo; John Jue; Michele A Turek; Trevor I Robinson; David Moher
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

View more
  5 in total

1.  Editorial on low-dose acetylsalicylic acid treatment and impact on short-term mortality in Staphylococcus aureus bloodstream infection: a propensity score-matched cohort study.

Authors:  Christian Schoergenhofer; Michael Schwameis; Heimo Lagler; Bernd Jilma
Journal:  Ann Transl Med       Date:  2016-05

Review 2.  Aspirin Effect on Staphylococcus aureus-Platelet Interactions During Infectious Endocarditis.

Authors:  Nadji Hannachi; Gilbert Habib; Laurence Camoin-Jau
Journal:  Front Med (Lausanne)       Date:  2019-10-15

3.  The role of antiaggregant agents and anticoagulants in the prevention of aortic valve endocarditis: A double-cohort retrospective study.

Authors:  Hanne Theys; Jef Van den Eynde; Marie-Christine Herregods; Philippe Moreillon; Ruth Heying; Wouter Oosterlinck
Journal:  JTCVS Open       Date:  2021-10-26

4.  Strain-dependent interactions of Streptococcus gallolyticus subsp. gallolyticus with human blood cells.

Authors:  Imke Grimm; Melanie Weinstock; Ingvild Birschmann; Jens Dreier; Cornelius Knabbe; Tanja Vollmer
Journal:  BMC Microbiol       Date:  2017-10-27       Impact factor: 3.605

Review 5.  Staphylococcus aureus and Neutrophil Extracellular Traps: The Master Manipulator Meets Its Match in Immunothrombosis.

Authors:  Severien Meyers; Marilena Crescente; Peter Verhamme; Kimberly Martinod
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-02-03       Impact factor: 8.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.